Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Morgan Stanley reckons"


5 mentions found


Under-the-radar stock picks Morgan Stanley reckons the way to play the obesity theme in Asia is through names involved in GLP-1 drug development that "could find upside in burgeoning overseas markets." Calling it "top beneficiary as global demand for GLP-1 drugs significantly outpaces capacity," Morgan Stanley has an overweight rating on the stock. Morgan Stanley has an investment horizon of just over six months for WuXi AppTec and Innovent and over 12 months for Chugai and EBOS. Morgan Stanley's analysts estimate that worldwide sales of Orforglipron could hit $7 billion in 2023. Elsewhere, it sees opportunities for EBOS following the Australian government's approval for it to distribute obesity drugs.
Persons: Eli Lilly, Morgan, Sean Wu, Morgan Stanley's, Health Organization's, Morgan Stanley, Chugai, Goldman, EBOS, CNBC's Michael Bloom Organizations: Novo Nordisk, Health, WHO, BMI, WuXi AppTec, Australian, Hong Kong Stock Exchange, China Health Care, Goldman Sachs, Health Care Equity, Zealand ETF Locations: U.S, Asia, Asia Pacific, Australia, GLP, WuXi, China, Japan, New Zealand, Zealand
With economic and monetary policy outlooks varying, currency moves are increasingly out of sync with each other. More pain is also anticipated for the yuan, trading near seven-month lows, as well as smaller Asian currencies. It's continuing to weaken against some European currencies and also Latin American currencies," he said. MULTI-LAYERED CRISISKit Juckes, head of FX strategy at Societe Generale, said the focus on monetary policy differences was also a result of uncertainties elsewhere. "We've got a one-in-a-100-years pandemic and once-in-75-years war and a-once-in-25-years energy crisis all thrown into the mix together," said SocGen's Juckes.
Persons: Yen, Pound, Jordan Rochester, Nomura, Lee Hardman, Hardman, Juckes, Morgan Stanley reckons, We've, SocGen's, You’ve, Dhara Ranasinghe, Alun John, John Stonestreet Organizations: The Bank of, European Central Bank, Reuters Graphics Rochester, Societe Generale, Bank of Japan, Thomson Locations: Europe, COVID, Ukraine, The Bank of Japan, United States, Beijing, Scandinavia
AI’s deflationary winds will blow away profits
  + stars: | 2023-06-27 | by ( Francesco Guerrera | ) www.reuters.com   time to read: +6 min
LONDON, June 27 (Reuters Breakingviews) - The prevailing expectation for artificial intelligence’s (AI’s) impact on humans is laden with doom. Yet the history of technological innovation suggests humans will see at least one tangible benefit from AI: lower prices for what they consume. One innovation that could give consumers an advantage over companies is AI agents. Streaming services like Netflix (NFLX.O) and Walt Disney’s (DIS.N) Disney+ could also suffer if AI agents take off. Junior lawyers, call centre operators and advertising copywriters, to name but a few, should probably be afraid, very afraid of AI’s looming threat.
Persons: , Geena Davis, David Cronenberg’s, Goldman Sachs, Morgan Stanley, Morgan Stanley reckons, HelloFresh, Walt Disney’s, Peter Thal Larsen, Oliver Taslic Organizations: Reuters, Goldman, McKinsey, Nvidia, May, Reuters Graphics Reuters, U.S . Bureau of Labor Statistics, Bureau of Labor Statistics, Netflix, Deloitte, Thomson Locations: United States, Mallorca
NEW YORK, Jan 10 (Reuters Breakingviews) - Microsoft (MSFT.O) is mulling a heads-I-win, tails-I-also win, AI deal. A mooted $10 billion investment, reported by Semafor, in the maker of the popular ChatGPT, could reshape Microsoft’s software business. And the investment is a pittance compared to Microsoft’s market capitalization of $1.7 trillion and $107 billion of cash on hand. Even then, Microsoft’s investment may not be wasted. The proposed investment means OpenAI can grow its business faster, which also benefits Azure, a part of Microsoft that investors value highly.
NEW YORK, Jan 10 (Reuters Breakingviews) - Microsoft (MSFT.O) is mulling a heads-I-win, tails-I-also win, AI deal. A mooted $10 billion investment, reported by Semafor, in the maker of the popular ChatGPT, could reshape Microsoft’s software business. And the investment is a pittance compared to Microsoft’s market capitalization of $1.7 trillion and $107 billion of cash on hand. Even then, Microsoft’s investment may not be wasted. The proposed investment means OpenAI can grow its business faster, which also benefits Azure, a part of Microsoft that investors value highly.
Total: 5